Skip to main content

ELVN

Enliven Therapeutics, Inc.
$49.82 +1.06 (+2.17%) At close · Jul 2
Market Cap
$3.03B
Shares
60,904,946

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 174
Total Value: $2,509,434,371
Total Shares: 64,015,658
Showing 1–100 of 182 holdings by value · page 1 of 2

Institutional Ownership Trend

14 quarters

Holder Concentration

Across 174 13F filers
Top Holder
12.4%
Jun 2023 → Mar 2026 · range 12.4% – 24.3%
of institutional value
Top 5
41.9%
Jun 2023 → Mar 2026 · range 41.9% – 64.6%
of institutional value
Top 10
59.8%
Jun 2023 → Mar 2026 · range 59.8% – 89.5%
of institutional value
HHI
500
Jun 2023 → Mar 2026 · range 500 – 1,142
Broadly held
Showing 100 of 182
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1672619 CUSIP 29337E102 13F (30d) 5 filings 4 filers Visit website Investor relations